Skip to content
Disclosery

Royalty Pharma Sub-Manager, LLC

Follow

13F filer, CIK 2081668, New York, NY

Royalty Pharma Sub-Manager, LLC reported $172,764,205 across 4 holdings for the quarter ended 2026-03-31, in a 13F-HR/A filed 2026-08-21.

Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0002081668-26-000017

Period
2026-03-31
Reported value
$173M
Holdings
4
Top 10 weight
100%
New
0
Sold out
0

Part of the filer group Royalty Pharma Sub-Manager, LLC

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ZBIOadded+1,125,000$22M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q1 2026

Share positions as resolved from 13F-HR/A 0002081668-26-000017, largest first. % of portfolio is the value over $172,764,205, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 980,392 shares; 2026Q1: 980,392 shares 980,392$64.6M37.4%0Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,263,150 shares; 2026Q1: 2,388,150 shares 2,388,150$46.7M27.02%+1,125,000Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 3,846,154 shares; 2026Q1: 3,846,154 shares 3,846,154$36.6M21.19%0Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 2,936,507 shares; 2026Q1: 2,936,507 shares 2,936,507$24.8M14.38%0Timeline

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0002081668-26-000006 superseded2026-05-14acceptance time not in the bulk data set
13F-HR/A 0002081668-26-000017 baserestatement2026-08-21acceptance time not in the bulk data set